Assembly Biosciences, Inc. Operating Cash Flow
Assembly Biosciences, Inc. (ASMB) reported Operating Cash Flow of -$37.59 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- Assembly Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$15.49M.
- Assembly Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$22.10M.
- Assembly Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $14.24M.
- Assembly Biosciences, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$15.13M.
- Assembly Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$41.09M.
- Assembly Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$51.12M, a 324.76% decline from fiscal 2023.
- Assembly Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2023 was $22.74M.
- Assembly Biosciences, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$84.46M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed | Net Cash Provided by (Used in) Operating Activities 69 month | Net Cash Provided by (Used in) Operating Activities 72 month | Net Cash Provided by (Used in) Operating Activities 75 month | Net Cash Provided by (Used in) Operating Activities 78 month | Net Cash Provided by (Used in) Operating Activities 81 month | Net Cash Provided by (Used in) Operating Activities 84 month | Net Cash Provided by (Used in) Operating Activities 87 month | Net Cash Provided by (Used in) Operating Activities 90 month | Net Cash Provided by (Used in) Operating Activities 93 month | Net Cash Provided by (Used in) Operating Activities 96 month | Net Cash Provided by (Used in) Operating Activities 99 month | Net Cash Provided by (Used in) Operating Activities 102 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$15.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$37.59M 10-Q · filed 2026-08-13 | -$23.35M derived: sum of 3 quarters · filed 2026-08-13 | -$38.48M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2026-03-31 | -$22.10M 10-Q · filed 2026-05-07 | -$7.86M derived: sum of 2 quarters · filed 2026-05-07 | -$22.99M derived: sum of 3 quarters · filed 2026-05-07 | -$39.75M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-12-31 | $14.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$896.00K derived: sum of 2 quarters · filed 2026-03-19 | -$17.65M derived: sum of 3 quarters · filed 2026-08-13 | -$41.09M 10-K · filed 2026-03-19 | ||||||||||||||||
| 2025-09-30 | -$15.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$31.89M derived: sum of 2 quarters · filed 2026-08-13 | -$55.33M 10-Q · filed 2025-11-10 | -$55.74M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-06-30 | -$16.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$40.20M 10-Q · filed 2026-08-13 | -$40.60M derived: sum of 3 quarters · filed 2026-08-13 | -$55.85M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||||||
| 2025-03-31 | -$23.44M 10-Q · filed 2026-05-07 | -$23.85M derived: sum of 2 quarters · filed 2026-05-07 | -$39.09M derived: sum of 3 quarters · filed 2026-05-07 | -$56.19M derived: sum of 4 quarters · filed 2026-05-07 | ||||||||||||||||
| 2024-12-31 | -$407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$15.65M derived: sum of 2 quarters · filed 2026-03-19 | -$32.75M derived: sum of 3 quarters · filed 2026-03-19 | -$51.12M 10-K · filed 2026-03-19 | ||||||||||||||||
| 2024-09-30 | -$15.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$32.35M derived: sum of 2 quarters · filed 2025-11-10 | -$50.71M 10-Q · filed 2025-11-10 | $22.94M derived: sum of 4 quarters · filed 2025-11-10 | ||||||||||||||||
| 2024-06-30 | -$17.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$35.47M 10-Q · filed 2025-08-06 | $38.18M derived: sum of 3 quarters · filed 2025-08-06 | $24.33M derived: sum of 4 quarters · filed 2025-08-06 | ||||||||||||||||
| 2024-03-31 | -$18.36M 10-Q · filed 2025-05-08 | $55.28M derived: sum of 2 quarters · filed 2025-05-08 | $41.44M derived: sum of 3 quarters · filed 2025-05-08 | $27.81M derived: sum of 4 quarters · filed 2025-05-08 | ||||||||||||||||
| 2023-12-31 | $73.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $59.80M derived: sum of 2 quarters · filed 2025-03-20 | $46.17M derived: sum of 3 quarters · filed 2025-03-20 | $22.74M 10-K · filed 2025-03-20 | ||||||||||||||||
| 2023-09-30 | -$13.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$27.48M derived: sum of 2 quarters · filed 2024-11-07 | -$50.90M 10-Q · filed 2024-11-07 | -$70.16M derived: sum of 4 quarters · filed 2024-11-07 | ||||||||||||||||
| 2023-06-30 | -$13.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$37.06M 10-Q · filed 2024-08-08 | -$56.31M derived: sum of 3 quarters · filed 2024-08-08 | -$76.13M derived: sum of 4 quarters · filed 2024-08-08 | ||||||||||||||||
| 2023-03-31 | -$23.43M 10-Q · filed 2024-05-08 | -$42.68M derived: sum of 2 quarters · filed 2024-05-08 | -$62.50M derived: sum of 3 quarters · filed 2024-05-08 | -$80.39M derived: sum of 4 quarters · filed 2024-05-08 | ||||||||||||||||
| 2022-12-31 | -$19.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$39.08M derived: sum of 2 quarters · filed 2024-03-28 | -$56.96M derived: sum of 3 quarters · filed 2024-03-28 | -$84.46M 10-K · filed 2024-03-28 | ||||||||||||||||
| 2022-09-30 | -$19.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$37.71M derived: sum of 2 quarters · filed 2023-11-08 | -$65.21M 10-Q · filed 2023-11-08 | -$84.57M derived: sum of 4 quarters · filed 2023-11-08 | ||||||||||||||||
| 2022-06-30 | -$17.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$45.39M 10-Q · filed 2023-08-09 | -$64.75M derived: sum of 3 quarters · filed 2023-08-09 | -$83.63M derived: sum of 4 quarters · filed 2023-08-09 | ||||||||||||||||
| 2022-03-31 | -$27.50M 10-Q · filed 2023-05-04 | -$46.86M derived: sum of 2 quarters · filed 2023-05-04 | -$65.75M derived: sum of 3 quarters · filed 2023-05-04 | -$87.55M derived: sum of 4 quarters · filed 2023-05-04 | ||||||||||||||||
| 2021-12-31 | -$19.36M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$38.24M derived: sum of 2 quarters · filed 2023-03-22 | -$60.05M derived: sum of 3 quarters · filed 2023-03-22 | -$93.40M 10-K · filed 2023-03-22 | ||||||||||||||||
| 2021-09-30 | -$18.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$40.69M derived: sum of 2 quarters · filed 2022-11-08 | -$74.03M 10-Q · filed 2022-11-08 | -$99.30M derived: sum of 4 quarters · filed 2022-11-08 | ||||||||||||||||
| 2021-06-30 | -$21.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$55.15M 10-Q · filed 2022-08-09 | -$80.42M derived: sum of 3 quarters · filed 2022-08-09 | -$69.78M derived: sum of 4 quarters · filed 2022-08-09 | ||||||||||||||||
| 2021-03-31 | -$33.34M 10-Q · filed 2022-05-12 | -$58.61M derived: sum of 2 quarters · filed 2022-05-12 | -$47.97M derived: sum of 3 quarters · filed 2022-05-12 | -$71.08M derived: sum of 4 quarters · filed 2022-05-12 | ||||||||||||||||
| 2020-12-31 | -$25.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$14.62M derived: sum of 2 quarters · filed 2022-03-11 | -$37.74M derived: sum of 3 quarters · filed 2022-03-11 | -$62.96M 10-K · filed 2022-03-11 | ||||||||||||||||
| 2020-09-30 | $10.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$12.47M derived: sum of 2 quarters · filed 2021-11-04 | -$37.69M 10-Q · filed 2021-11-04 | -$58.22M derived: sum of 4 quarters · filed 2021-11-04 | ||||||||||||||||
| 2020-06-30 | -$23.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$48.33M 10-Q · filed 2021-08-05 | -$68.86M derived: sum of 3 quarters · filed 2021-08-05 | -$87.46M derived: sum of 4 quarters · filed 2021-08-05 | ||||||||||||||||
| 2020-03-31 | -$25.22M 10-Q · filed 2021-05-06 | -$45.75M derived: sum of 2 quarters · filed 2021-05-06 | -$64.34M derived: sum of 3 quarters · filed 2021-05-06 | -$85.35M derived: sum of 4 quarters · filed 2021-05-06 | ||||||||||||||||
| 2019-12-31 | -$20.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$39.12M derived: sum of 2 quarters · filed 2021-02-25 | -$60.13M derived: sum of 3 quarters · filed 2021-02-25 | -$84.07M 10-K · filed 2021-02-25 | ||||||||||||||||
| 2019-09-30 | -$18.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$39.60M derived: sum of 2 quarters · filed 2020-11-05 | -$63.54M 10-Q · filed 2020-11-05 | -$80.27M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||||||
| 2019-06-30 | -$21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$44.94M 10-Q · filed 2020-08-05 | -$61.67M derived: sum of 3 quarters · filed 2021-02-25 | -$78.36M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||||||
| 2019-03-31 | -$23.94M 10-Q · filed 2020-05-08 | -$40.67M derived: sum of 2 quarters · filed 2021-02-25 | -$57.35M derived: sum of 3 quarters · filed 2021-02-25 | -$73.40M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||||||||||
| 2018-12-31 | -$16.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$33.41M derived: sum of 2 quarters · filed 2021-02-25 | -$49.46M derived: sum of 3 quarters · filed 2021-02-25 | -$64.96M 10-K · filed 2021-02-25 | ||||||||||||||||
| 2018-09-30 | -$16.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$32.73M derived: sum of 2 quarters · filed 2019-11-07 | -$48.23M 10-Q · filed 2019-11-07 | -$48.23M 10-Q · filed 2018-11-08 | -$58.00M derived: sum of 4 quarters · filed 2020-03-04 | |||||||||||||||
| 2018-06-30 | -$16.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$31.55M 10-Q · filed 2019-08-05 | -$31.55M 10-Q · filed 2018-08-08 | -$41.32M derived: sum of 3 quarters · filed 2020-03-04 | -$52.27M derived: sum of 4 quarters · filed 2020-03-04 | |||||||||||||||
| 2018-03-31 | -$15.50M 10-Q · filed 2019-05-09 | -$15.50M 10-Q · filed 2018-05-07 | -$25.27M derived: sum of 2 quarters · filed 2020-03-04 | -$36.23M derived: sum of 3 quarters · filed 2020-03-04 | -$48.58M derived: sum of 4 quarters · filed 2020-03-04 | |||||||||||||||
| 2017-12-31 | -$9.77M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04 | -$20.73M derived: sum of 2 quarters · filed 2020-03-04 | -$33.08M derived: sum of 3 quarters · filed 2020-03-04 | $1.86M 10-K · filed 2020-03-04 | $1.86M 10-K · filed 2018-03-08 | |||||||||||||||
| 2017-09-30 | -$10.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$23.31M derived: sum of 2 quarters · filed 2018-11-08 | $11.63M 10-Q · filed 2018-11-08 | $590.56K derived: sum of 4 quarters · filed 2019-02-28 | ||||||||||||||||
| 2017-06-30 | -$12.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $22.59M 10-Q · filed 2018-08-08 | $11.55M derived: sum of 3 quarters · filed 2019-02-28 | |||||||||||||||||
| 2017-03-31 | $34.94M 10-Q · filed 2018-05-07 | $23.91M derived: sum of 2 quarters · filed 2019-02-28 | ||||||||||||||||||
| 2016-12-31 | -$11.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$34.88M 10-K · filed 2019-02-28 | -$34.88M 10-K · filed 2018-03-08 | |||||||||||||||||
| 2016-09-30 | -$23.84M 10-Q · filed 2017-11-01 | |||||||||||||||||||
| 2015-12-31 | -$5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$10.64M derived: sum of 2 quarters · filed 2018-03-08 | -$15.02M derived: sum of 3 quarters · filed 2018-03-08 | -$18.70M 10-K · filed 2018-03-08 | ||||||||||||||||
| 2015-09-30 | -$5.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$9.57M derived: sum of 2 quarters · filed 2015-11-09 | -$13.24M 10-Q · filed 2015-11-09 | -$16.84M derived: sum of 4 quarters · filed 2015-11-09 | ||||||||||||||||
| 2015-06-30 | -$4.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$8.06M 10-Q · filed 2015-08-13 | -$11.65M derived: sum of 3 quarters · filed 2015-08-13 | -$15.52M derived: sum of 4 quarters · filed 2015-11-09 | ||||||||||||||||
| 2015-03-31 | -$3.67M 10-Q · filed 2015-05-08 | -$7.27M derived: sum of 2 quarters · filed 2015-05-08 | -$11.14M derived: sum of 3 quarters · filed 2015-11-09 | -$13.46M derived: sum of 4 quarters · filed 2015-11-09 | ||||||||||||||||
| 2014-12-31 | -$3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$7.47M derived: sum of 2 quarters · filed 2015-11-09 | -$9.79M derived: sum of 3 quarters · filed 2015-11-09 | -$14.97M 10-K · filed 2015-03-16 | ||||||||||||||||
| 2014-09-30 | -$3.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$6.20M derived: sum of 2 quarters · filed 2015-11-09 | -$11.38M 10-Q · filed 2015-11-09 | -$16.77M derived: sum of 4 quarters · filed 2015-11-09 | ||||||||||||||||
| 2014-06-30 | -$2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$7.51M 10-Q · filed 2015-08-13 | -$12.90M derived: sum of 3 quarters · filed 2015-08-13 | -$17.55M derived: sum of 4 quarters · filed 2015-08-13 | ||||||||||||||||
| 2014-03-31 | -$5.19M 10-Q · filed 2015-05-08 | -$10.58M derived: sum of 2 quarters · filed 2015-05-08 | -$15.23M derived: sum of 3 quarters · filed 2015-05-08 | -$18.61M derived: sum of 4 quarters · filed 2015-05-08 | -$84.80M 10-Q · filed 2014-05-14 | |||||||||||||||
| 2013-12-31 | -$5.39M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$10.05M derived: sum of 2 quarters · filed 2015-03-16 | -$13.43M derived: sum of 3 quarters · filed 2015-03-16 | -$17.80M 10-K · filed 2015-03-16 | -$79.61M 10-K · filed 2014-03-31 | |||||||||||||||
| 2013-09-30 | -$4.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-17 | -$8.03M derived: sum of 2 quarters · filed 2014-11-17 | -$12.40M 10-Q · filed 2014-11-17 | -$15.47M derived: sum of 4 quarters · filed 2014-11-17 | -$74.22M 10-Q · filed 2013-11-12 | |||||||||||||||
| 2013-06-30 | -$3.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$7.75M 10-Q · filed 2014-08-14 | -$10.82M derived: sum of 3 quarters · filed 2014-08-14 | -$16.10M derived: sum of 4 quarters · filed 2014-08-14 | -$69.57M 10-Q · filed 2013-08-09 | |||||||||||||||
| 2013-03-31 | -$4.37M 10-Q · filed 2014-05-14 | -$7.44M derived: sum of 2 quarters · filed 2014-05-14 | -$12.72M derived: sum of 3 quarters · filed 2014-05-14 | -$19.66M derived: sum of 4 quarters · filed 2014-05-14 | -$66.19M 10-Q · filed 2013-05-10 | |||||||||||||||
| 2012-12-31 | -$3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$8.35M derived: sum of 2 quarters · filed 2014-03-31 | -$15.29M derived: sum of 3 quarters · filed 2014-03-31 | -$21.38M 10-K · filed 2014-03-31 | -$61.82M 10-K · filed 2013-03-18 | |||||||||||||||
| 2012-09-30 | -$5.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$12.22M derived: sum of 2 quarters · filed 2013-11-12 | -$18.31M 10-Q · filed 2013-11-12 | -$34.64M derived: sum of 4 quarters · filed 2013-11-12 | -$58.75M 10-Q · filed 2012-11-13 | |||||||||||||||
| 2012-06-30 | -$6.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$13.03M 10-Q · filed 2013-08-09 | -$29.36M derived: sum of 3 quarters · filed 2013-08-09 | -$33.43M derived: sum of 4 quarters · filed 2013-08-09 | -$53.46M 10-Q · filed 2012-08-09 | |||||||||||||||
| 2012-03-31 | -$6.09M 10-Q · filed 2013-05-10 | -$22.42M derived: sum of 2 quarters · filed 2013-05-10 | -$26.49M derived: sum of 3 quarters · filed 2013-05-10 | -$29.34M derived: sum of 4 quarters · filed 2013-05-10 | -$46.53M 10-Q · filed 2012-05-09 | |||||||||||||||
| 2011-12-31 | -$16.33M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$20.40M derived: sum of 2 quarters · filed 2013-03-18 | -$23.25M derived: sum of 3 quarters · filed 2013-03-18 | -$25.07M 10-K · filed 2013-03-18 | -$40.44M 10-K · filed 2012-03-14 | |||||||||||||||
| 2011-09-30 | -$4.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -$6.92M derived: sum of 2 quarters · filed 2012-11-13 | -$8.74M 10-Q · filed 2012-11-13 | -$9.95M derived: sum of 4 quarters · filed 2013-03-18 | -$24.11M 10-Q/A · filed 2011-11-18 | |||||||||||||||
| 2011-06-30 | -$2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$4.67M 10-Q · filed 2012-08-09 | -$5.89M derived: sum of 3 quarters · filed 2013-03-18 | -$6.91M derived: sum of 4 quarters · filed 2013-03-18 | -$20.04M 10-Q · filed 2011-08-15 | |||||||||||||||
| 2011-03-31 | -$1.81M 10-Q · filed 2012-05-09 | -$3.03M derived: sum of 2 quarters · filed 2013-03-18 | -$4.05M derived: sum of 3 quarters · filed 2013-03-18 | |||||||||||||||||
| 2010-12-31 | -$1.22M derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-18 | -$2.24M derived: sum of 2 quarters · filed 2013-03-18 | -$5.21M 10-K · filed 2013-03-18 | |||||||||||||||||
| 2010-09-30 | -$1.02M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2011-11-18 | -$4.00M 10-Q/A · filed 2011-11-18 | ||||||||||||||||||
| 2010-06-30 | -$2.97M 10-Q · filed 2011-08-15 | |||||||||||||||||||
| 2009-12-31 | -$3.48M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |